Oregon Public Employees Retirement Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28M	Buy	39,917 +500	+1%	+$27.4K	0.02%	518
2026 Q1	$2.23M	Buy	39,417 +1,277	+3%	+$74.5K	0.03%	472
2025 Q4	$2.27M	Sell	38,140 -500	-1%	-$27.2K	0.03%	463
2025 Q3	$2.09M	Sell	38,640 -600	-2%	-$34.3K	0.03%	485
2025 Q2	$2.16M	Buy	39,240 +600	+2%	+$35.3K	0.04%	400
2025 Q1	$2.73M	Sell	38,640 -98	-0.3%	-$6.59K	0.05%	290
2024 Q4	$2.55M	Buy	38,738 +164	+0.4%	+$11K	0.05%	329
2024 Q3	$2.71M	Sell	38,574 -826	-2%	-$69K	0.05%	312
2024 Q2	$3.24M	Buy	+39,400	New	+$3.28M	0.06%	234
2020 Q4	–	Sell	-20,289	Closed	-$1.54M	–	1605
2020 Q3	$1.54M	Sell	20,289 -1,200	-6%	-$121K	0.02%	576
2020 Q2	$2.65M	Sell	21,489 -15,611	-42%	-$1.55M	0.04%	378
2020 Q1	$3.13M	Buy	+37,100	New	+$3.2M	0.05%	309
2016 Q3	–	Sell	-7,200	Closed	-$560K	–	934
2016 Q2	$560K	Sell	7,200 -400	-5%	-$34K	0.01%	903
2016 Q1	$627K	Hold	7,600	–	–	0.01%	863
2015 Q4	$796K	Sell	7,600 -7,100	-48%	-$741K	0.02%	783
2015 Q3	$1.55M	Buy	14,700 +400	+3%	+$53.4K	0.04%	519
2015 Q2	$1.96M	Buy	14,300 +8,100	+131%	+$1M	0.05%	465
2015 Q1	$773K	Buy	6,200 +500	+9%	+$53K	0.02%	827
2014 Q4	$515K	Buy	5,700 +5,500	+2,750%	+$457K	0.01%	902
2014 Q3	$14K	Hold	200	–	–	﹤0.01%	1019
2014 Q2	$12K	Hold	200	–	–	﹤0.01%	1011
2014 Q1	$14K	Hold	200	–	–	﹤0.01%	1005
2013 Q4	$14K	Buy	+200	New	+$13.6K	﹤0.01%	1007

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Oregon Public Employees Retirement Fund's BMRN Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its BioMarin Pharmaceuticals (BMRN) stake by 1.3% in Q2 2026, buying an estimated $27.4K and bringing the position to 39,917 shares worth $2.28M. The position accounts for 0.02% of the portfolio, ranked #518.

Oregon Public Employees Retirement Fund first reported a position in BMRN in Q4 2013 and has held it in 23 quarters since. The position peaked at $3.24M in Q2 2024. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Oregon Public Employees Retirement Fund held 39,917 shares of BioMarin Pharmaceuticals worth $2.28M as of Q2 2026.
Oregon Public Employees Retirement Fund bought 500 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $27.4K.
BioMarin Pharmaceuticals made up 0.02% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #518 holding.
Oregon Public Employees Retirement Fund first reported a position in BioMarin Pharmaceuticals in Q4 2013 and has held it in 23 quarters since.
Oregon Public Employees Retirement Fund's BioMarin Pharmaceuticals position peaked at $3.24M in Q2 2024.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.